Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078836 | SCV000332023 | benign | not specified | 2015-07-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000513546 | SCV000529561 | likely benign | not provided | 2021-11-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000513546 | SCV000609324 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BP7, BS2 |
Invitae | RCV001081533 | SCV000650145 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000513546 | SCV000843232 | benign | not provided | 2017-11-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003935019 | SCV004752322 | benign | PLEC-related condition | 2021-03-03 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000513546 | SCV001800381 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000513546 | SCV001964024 | likely benign | not provided | no assertion criteria provided | clinical testing |